about
Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverriniInteractive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosisHypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesReview series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell functionCellular and molecular mechanisms of fibrosisA role for MCP-1/CCR2 in interstitial lung disease in children.In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubesCytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDDendritic cells in lung immunopathologyRole of Bone Marrow-Derived Fibroblasts in Renal FibrosisLeukocytes: The Double-Edged Sword in FibrosisHIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatmentPleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative DiseasesImmunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsWhat is the best way to measure renal fibrosis?: A pathologist’s perspectiveDiverse functions of matrix metalloproteinases during fibrosisGammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodentsHost responses in tissue repair and fibrosisThe multifaceted aspects of interstitial lung disease in rheumatoid arthritisTherapeutic strategies for preventing skeletal muscle fibrosis after injuryInflammatory cytokines in pulmonary hypertensionRole of IL-4Rα during acute schistosomiasis in miceGalectin-3: its role in asthma and potential as an anti-inflammatory targetReview article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsA New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and FibrosisMyofibroblasts and lung fibrosis induced by carbon nanotube exposureNovel concepts in radiation-induced cardiovascular disease.Obesity: An Immunometabolic PerspectiveThe molecular basis of hypertrophic scarsncRNA-regulated immune response and its role in inflammatory lung diseasesAlong the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to MammalsThe stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocityPolymorphisms in interleukin 17A gene and coal workers' pneumoconiosis risk in a Chinese populationYKL-40 is a Protective Biomarker for Fatty Liver in World Trade Center Particulate Matter-Exposed FirefightersPulmonary fibrosis: pathogenesis, etiology and regulationA 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterialsPolymorphisms in inflammasome genes and risk of coal workers' pneumoconiosis in a Chinese populationMeta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterialsMina, an Il4 repressor, controls T helper type 2 biasMechanisms of fibrosis: therapeutic translation for fibrotic disease
P2860
Q21266569-9254B462-173D-4F6E-BCA6-F83EF6793DD5Q23914450-20A7DF86-D2BD-44C9-9625-A41998F3961EQ24595036-101F97DF-E9D0-4364-9D4F-089B76884D8CQ24643396-CA21832D-E343-45A3-86B0-09CAA691DB3DQ24648892-52B4E950-BA53-48A2-BEA9-FA5864359D3DQ24811760-AB3CE407-7DD0-4931-9419-A108B5B289CDQ26342943-0403A212-F510-4D03-8103-9B135F04E181Q26740540-E9E4C89A-BE8B-4EA1-8D5B-EB41C9D85F3EQ26743564-5BEAC5C8-C428-48F1-86A0-6B23B0921F9DQ26768585-CFADCC69-E37E-44B2-9BC3-92406394F7EAQ26777122-E8243F01-B1F5-4F19-A7E9-BCF3938C9EB4Q26777241-2225644D-EB7E-42AB-BA01-BC9AB7DDFD1BQ26779081-CE6B26D3-D8C0-402F-A071-453B36A7984FQ26781538-E13172DB-7346-4814-830D-91049302D657Q26796641-D13F5DA8-CEF6-4EC6-9DA5-9BFE419CEA54Q26825368-5F2072D7-9200-48ED-87B1-C4DB4F0D5852Q26829291-E574A15D-A257-44B1-B579-EBA7EE78CEE8Q26852800-7947E177-C866-4E52-8195-91E0E4235CFBQ26861557-70727388-660D-496B-B1D7-D723D3988704Q27001085-EF1EE0C4-3F4B-4B09-8E6A-E2A91C2A2ECBQ27007510-224202B3-4871-4BE9-85F7-49B065E8F826Q27010514-190B36A4-D7E4-411B-9817-F2CD07A4C22AQ27023534-C3CEFFF3-12F8-46ED-9FB1-34230EA7DEC6Q27025680-66796038-9B50-44D9-B47A-B5ACB2D942D0Q27333100-5866E00D-C77A-4FDB-9BA3-7C6D12208C1DQ27969008-BB402726-AA84-4C27-A15F-70C2CF1056E1Q28071302-4AA8E1ED-09CA-4D99-98E0-64AB35A2188DQ28072140-341A6D64-71A0-49C3-A0D4-4324D6A1932EQ28073238-8A55B2C3-BA45-4DD4-9859-3C430DB0CD00Q28082698-EACCCB67-6088-4629-AC2A-B1B668A2FD82Q28083360-D28FA9EE-9081-4970-A6E1-75A48E577CE7Q28085495-BB50B14A-E626-45CB-B380-1E91DD70590BQ28384688-87D27DC3-CB7B-4DAA-9CEF-968435B9639BQ28388339-98053733-1AE4-4253-B094-D7CC0FA3A67FQ28388425-78015C89-81C4-4A5C-9666-550CE638DD82Q28389632-A762B928-93B2-43CE-85CC-3076A65F4218Q28390069-ABB61851-3A75-40E7-83EC-9331E8B93E7DQ28394109-BBAAB419-DB5B-46FF-8252-54A3E0CD3EAFQ28511123-A8A0DCDC-B191-49D9-B93D-FD0334088180Q29620307-32AA7136-7605-4473-966E-AA95603D45A6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@ast
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@en
type
label
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@ast
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@en
prefLabel
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@ast
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@en
P2860
P356
P1476
Fibrotic disease and the T(H)1/T(H)2 paradigm.
@en
P2093
Thomas A Wynn
P2860
P304
P356
10.1038/NRI1412
P577
2004-08-01T00:00:00Z